Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous TAAs-loaded autologous dendritic cells AV-GBM-1

A preparation of autologous dendritic cells (DCs) loaded with immunogenic tumor-associated antigens (TAAs) derived from cultured autologous glioblastoma multiforme (GBM) tumor cells, with potential immunostimulatory and antineoplastic activities. Upon administration, the autologous TAA-loaded DCs AV-GBM-1 expose the immune system to the GBM neoantigens, which results in a cytotoxic T-lymphocyte (CTL)-mediated immune response against the autologous GBM cells leading to GBM cell lysis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:autologous dendritic cells loaded with autologous tumor associated antigens
autologous TAAs-loaded autologous DCs AV-GBM-1
neoantigen-loaded autologous dendritic cells AV-GBM-1
Code name:AV GBM 1
AV-GBM-1
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search